Genmab A/S (GMAB) Stock price, Description, News & Info
#Thinksabio latest news Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints...
#Thinksabio latest news Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints...
SEC Filing Update: #ATKR : $55.16 Sector: Industrials | YTD: 🔽 -32.29 % The SEC...
SEC Filing Update: #NBB : $15.93 Sector: Financial Services | YTD: 🔼+ 5.92 % The...
SEC Filing Update: #JBGS : $19.79 Sector: Real Estate | YTD: 🔼+ 28.17 % The...
SEC Filing Update: #FCT : $10.05 Sector: Financial Services | YTD: 🔽 -2.90 % The...
SEC Filing Update: #GLOB : $77.75 Sector: Technology | YTD: 🔽 -63.51 % The SEC...
SEC Filing Update: #IRON : $56.85 Sector: Healthcare | YTD: 🔽 -9.00 % The SEC...
SEC Filing Update: #PDT : $13.42 Sector: Financial Services | YTD: 🔼+ 5.59 % The...
SEC Filing Update: #TVTX : $16.27 Sector: Healthcare | YTD: 🔽 -14.23 % The SEC...
SEC Filing Update: #GDEC : $35.60 Sector: Others | YTD: 🔼+ 5.54 % The SEC...